These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6234272)

  • 1. The antimicrobial spectrum of norfloxacin.
    Newsom SW
    J Antimicrob Chemother; 1984 May; 13 Suppl B():25-31. PubMed ID: 6234272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norfloxacin, amoxycillin, cotrimoxazole and nalidixic acid. A summary of 3-day and 7-day therapy studies in the treatment of urinary tract infections.
    Vogel R; Deaney NB; Round EM; VandenBurg MJ; Currie WJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():113-20. PubMed ID: 6234271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative trial of norfloxacin and trimethoprim-sulfamethoxazole in the treatment of women with localized, acute, symptomatic urinary tract infections and antimicrobial effect on periurethral and fecal microflora.
    Haase DA; Harding GK; Thomson MJ; Kennedy JK; Urias BA; Ronald AR
    Antimicrob Agents Chemother; 1984 Oct; 26(4):481-4. PubMed ID: 6240223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin versus cotrimoxazole in the treatment of uncomplicated urinary tract infections--a multi-centre trial.
    Watt B; Chait I; Kelsey MC; Newsom SW; Newsom RA; Smith J; Toase PD; Deaney NB; Round EM; Vogel R
    J Antimicrob Chemother; 1984 May; 13 Suppl B():89-94. PubMed ID: 6234281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of norfloxacin versus cotrimoxazole in urinary tract infections.
    Guerra JG; Falconi E; Palomino JC; Benavente L; Antunez de Mayolo E
    Eur J Clin Microbiol; 1983 Jun; 2(3):260-5. PubMed ID: 6224684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of norfloxacin in urinary tract infection biological effects on vaginal and fecal flora.
    Schaeffer AJ; Sisney GA
    J Urol; 1985 Apr; 133(4):628-30. PubMed ID: 3157008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiclinic comparative study of norfloxacin and trimethoprim-sulfamethoxazole for treatment of urinary tract infections.
    Sabbaj J; Hoagland VL; Shih WJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):297-301. PubMed ID: 3158272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.
    Goldstein EJ; Alpert ML; Ginsberg BP
    Antimicrob Agents Chemother; 1985 Mar; 27(3):422-3. PubMed ID: 3158277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testing.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1983 Jun; 1(2):165-72. PubMed ID: 6232084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Norfloxacin versus cotrimoxazole in the treatment of lower urinary tract infections.
    Giamarellou H; Tsagarakis J; Petrikkos G; Daikos GK
    Eur J Clin Microbiol; 1983 Jun; 2(3):266-9. PubMed ID: 6224685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nitrofurans: a modern treatment for uncomplicated urinary infections?].
    Cahen P; Honderlick P
    Pathol Biol (Paris); 2000 Jun; 48(5):470-1. PubMed ID: 10949843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of norfloxacin and selected antimicrobial agents against urinary tract pathogens and Neisseria gonorrhoeae.
    Sweet RL; Ohm-Smith MJ; Hadley WK
    J Antimicrob Chemother; 1982 Dec; 10(6):553-7. PubMed ID: 6219085
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of urinary tract infection in the elderly.
    Bendall MJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():69-78. PubMed ID: 6234278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
    Esko E; Renkonen OV
    Scand J Infect Dis; 1985; 17(1):95-8. PubMed ID: 3158071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Petermüller C
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
    Khan MY; Gruninger RP; Nelson SM; Klicker RE
    Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
    Leigh DA; Smith EC; Marriner J
    J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro activity of norfloxacin and four other chemotherapeutics against urinary gram-negative isolates.
    Esposito S; Galante D; Pennucci C; Barba D; Limauro D; Scioli C
    Chemioterapia; 1984 Jun; 3(3):196-9. PubMed ID: 6241506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute cystitis in young women. Treatment with citrated nalidixic acid compared with co-trimoxazole.
    Butler AV; Cullen MJ; Parry MO; Sylvester DG; Speller DC
    Practitioner; 1983 May; 227(1379):833-5. PubMed ID: 6604266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.